Correlation Between Sonoma Pharmaceuticals and Petros Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Sonoma Pharmaceuticals and Petros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonoma Pharmaceuticals and Petros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonoma Pharmaceuticals and Petros Pharmaceuticals, you can compare the effects of market volatilities on Sonoma Pharmaceuticals and Petros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonoma Pharmaceuticals with a short position of Petros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonoma Pharmaceuticals and Petros Pharmaceuticals.
Diversification Opportunities for Sonoma Pharmaceuticals and Petros Pharmaceuticals
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Sonoma and Petros is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Sonoma Pharmaceuticals and Petros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Petros Pharmaceuticals and Sonoma Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonoma Pharmaceuticals are associated (or correlated) with Petros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Petros Pharmaceuticals has no effect on the direction of Sonoma Pharmaceuticals i.e., Sonoma Pharmaceuticals and Petros Pharmaceuticals go up and down completely randomly.
Pair Corralation between Sonoma Pharmaceuticals and Petros Pharmaceuticals
Given the investment horizon of 90 days Sonoma Pharmaceuticals is expected to generate 0.8 times more return on investment than Petros Pharmaceuticals. However, Sonoma Pharmaceuticals is 1.25 times less risky than Petros Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Petros Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest 321.00 in Sonoma Pharmaceuticals on August 28, 2024 and sell it today you would lose (28.00) from holding Sonoma Pharmaceuticals or give up 8.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sonoma Pharmaceuticals vs. Petros Pharmaceuticals
Performance |
| Timeline |
| Sonoma Pharmaceuticals |
| Petros Pharmaceuticals |
Sonoma Pharmaceuticals and Petros Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sonoma Pharmaceuticals and Petros Pharmaceuticals
The main advantage of trading using opposite Sonoma Pharmaceuticals and Petros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonoma Pharmaceuticals position performs unexpectedly, Petros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Petros Pharmaceuticals will offset losses from the drop in Petros Pharmaceuticals' long position.| Sonoma Pharmaceuticals vs. China Pharma Holdings | Sonoma Pharmaceuticals vs. Universe Pharmaceuticals | Sonoma Pharmaceuticals vs. Akanda Corp | Sonoma Pharmaceuticals vs. Petros Pharmaceuticals |
| Petros Pharmaceuticals vs. Eliem Therapeutics | Petros Pharmaceuticals vs. HCW Biologics | Petros Pharmaceuticals vs. Scpharmaceuticals | Petros Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |